AI assistant
Sending…
BIOVIE INC. — Director's Dealing 2019
Mar 14, 2019
35090_dirs_2019-03-14_8ddc3fd8-47ef-4c0b-b630-7c8860a94a58.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIOVIE INC. (bivi)
CIK: 0001580149
Period of Report: 2018-11-01
Reporting Person: MARKHAM PENELOPE (Chief Science Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| options | $0.25 | 2021-11-16 | Common Stock (100000) | Direct | |
| options | $0.1 | 2023-01-19 | Common Stock (100000) | Direct | |
| options | $0.025 | 2024-01-19 | Common Stock (100000) | Direct |
More from BIOVIE INC.
Interim / Quarterly Report
2026
May 11
Major Shareholding Notification
2026
Mar 25
Interim / Quarterly Report
2026
Feb 6
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9